Progress in the clinical application and correlation between glucose transporter-1 and / 生物医学工程学杂志
Journal of Biomedical Engineering
; (6): 399-404, 2021.
Article
em Zh
| WPRIM
| ID: wpr-879290
Biblioteca responsável:
WPRO
ABSTRACT
Because of the unobvious early symptoms and low 5-year survival rate, the early diagnosis and treatment is of great significance for patients with non-small cell lung cancer. Glucose transporter-1 is the most widely distributed glucose transporters in various tissue cells in the human body, whose expression in non-small cell lung cancer is closely related to the histological types, lymph node metastasis, degree of differentiation, progression and prognosis.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Carcinoma Pulmonar de Células não Pequenas
/
Compostos Radiofarmacêuticos
/
Fluordesoxiglucose F18
/
Tomografia por Emissão de Pósitrons
/
Proteínas Facilitadoras de Transporte de Glucose
/
Transportador de Glucose Tipo 1
/
Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada
/
Neoplasias Pulmonares
Tipo de estudo:
Screening_studies
Limite:
Humans
Idioma:
Zh
Revista:
Journal of Biomedical Engineering
Ano de publicação:
2021
Tipo de documento:
Article